IRIS UniCatt

Racioppi, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.944
NA - Nord America 7.146
AS - Asia 4.996
SA - Sud America 887
AF - Africa 166
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 33.172
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.735
US - Stati Uniti d'America 6.917
SG - Singapore 2.250
DE - Germania 1.897
CN - Cina 1.144
SE - Svezia 904
NL - Olanda 854
FR - Francia 725
BR - Brasile 715
UA - Ucraina 485
VN - Vietnam 428
GB - Regno Unito 351
IN - India 293
IE - Irlanda 216
ID - Indonesia 145
PL - Polonia 138
JP - Giappone 136
CA - Canada 131
FI - Finlandia 130
RU - Federazione Russa 124
HK - Hong Kong 111
BD - Bangladesh 109
CH - Svizzera 90
TR - Turchia 69
ES - Italia 64
AR - Argentina 63
MX - Messico 53
BE - Belgio 51
IQ - Iraq 47
ZA - Sudafrica 41
KR - Corea 30
PK - Pakistan 30
CI - Costa d'Avorio 25
EC - Ecuador 25
MA - Marocco 25
AT - Austria 24
CO - Colombia 24
AL - Albania 21
RO - Romania 21
AE - Emirati Arabi Uniti 18
AZ - Azerbaigian 18
IR - Iran 18
PH - Filippine 16
SA - Arabia Saudita 16
VE - Venezuela 16
CL - Cile 15
EG - Egitto 15
AU - Australia 14
GR - Grecia 13
IL - Israele 13
LT - Lituania 13
NP - Nepal 13
TN - Tunisia 13
JO - Giordania 12
MY - Malesia 12
NG - Nigeria 12
UZ - Uzbekistan 12
PE - Perù 10
CR - Costa Rica 9
CZ - Repubblica Ceca 9
TT - Trinidad e Tobago 8
TW - Taiwan 8
HU - Ungheria 7
PT - Portogallo 7
TH - Thailandia 7
BO - Bolivia 6
DZ - Algeria 6
EU - Europa 6
KE - Kenya 6
KG - Kirghizistan 6
LK - Sri Lanka 6
NZ - Nuova Zelanda 6
OM - Oman 6
PA - Panama 6
RS - Serbia 6
SN - Senegal 6
UY - Uruguay 6
BG - Bulgaria 5
BY - Bielorussia 5
HR - Croazia 5
IS - Islanda 5
LV - Lettonia 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
SM - San Marino 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DK - Danimarca 4
ET - Etiopia 4
HN - Honduras 4
JM - Giamaica 4
KW - Kuwait 4
LB - Libano 4
SI - Slovenia 4
BB - Barbados 3
CV - Capo Verde 3
LU - Lussemburgo 3
NI - Nicaragua 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BZ - Belize 2
Totale 33.127
Salva come PNG Salva come JPEG
Città #
Milan 1.315
Singapore 1.210
Rome 1.184
Chandler 988
Ashburn 787
San Jose 667
Naples 410
Jacksonville 265
Florence 255
Turin 238
Beijing 231
Los Angeles 218
Dublin 208
San Mateo 205
Bologna 188
New York 171
Ann Arbor 169
Palermo 161
Bari 159
Ho Chi Minh City 147
Nanjing 147
Wilmington 140
Jakarta 134
Lauterbourg 134
Catania 124
Genoa 118
Hanoi 106
Verona 104
Munich 103
Hong Kong 98
Frankfurt am Main 96
Hefei 96
The Dalles 91
Dearborn 90
São Paulo 87
Bremen 85
Nürnberg 85
Kraków 82
Tokyo 82
Boston 81
Nanchang 75
Woodbridge 75
Lawrence 71
Brescia 69
Moscow 69
Houston 64
Marseille 63
Redwood City 63
Dallas 59
Padova 58
Santa Clara 54
Cagliari 51
Seattle 49
Venice 49
Buffalo 47
Taranto 47
Parma 46
Hyderabad 43
Perugia 42
Pescara 42
Bergamo 41
Chicago 41
Lancaster 39
Ottawa 39
Princeton 39
Reggio Emilia 39
Brussels 38
Messina 38
Mountain View 36
Salerno 36
Cattolica 34
Fairfield 32
Livorno 32
Orem 32
Paris 32
Toronto 32
Atlanta 31
Helsinki 31
Stockholm 31
London 30
Amsterdam 29
Lucca 29
Redmond 29
Tianjin 29
Kadoma 28
Falls Church 27
Modena 27
Montreal 27
Trieste 27
Kent 26
Kunming 26
Monza 26
Rimini 26
Abidjan 25
Boardman 25
Johannesburg 25
Novara 24
Seoul 24
Augusta 23
Belo Horizonte 22
Totale 13.622
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 12.118
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.231
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 956
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 612
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 431
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 359
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 327
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 325
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 318
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 251
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 237
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position 232
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 216
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 209
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 202
The occult urothelial cancer 200
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 193
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 187
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 185
Haemodynamic changes detected during open prostatectomy and transurethral resection for benign prostatic hyperplasia 183
Male infertility: non-surgical therapy 180
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 172
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 172
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 171
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 170
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 170
[Overactive bladder syndrome: the social and economic perspective] 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 169
Size of Bladder Cancers: Correlation among Different Types of Measurement 168
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 168
Bladder and prostate metastasis from small cell lung cancer: a rare entity 168
Imaging in prostate cancer diagnosis: present role and future perspectives 167
Hot topics in urological health economics. A mini review 166
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 163
Therapeutic strategies in penile cancer: state of the art 162
Antibiotic prophylaxis in urology 162
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 161
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 161
Acid-base and electrolyte balance in urinary intestinal orthotopic reservoir: ileocecal neobladder compared with ileal neobladder 158
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome 158
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes 158
Advanced bladder cancer: New agents and new approaches. A review 156
Imaging in prostate cancer staging: present role e future perspectives 156
Imaging of renal cell carcinoma: state of the art and recent advances 155
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 155
NBI: results review 153
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 153
Long-term behaviour of secretory immunity in ileocecal and ileal orthotopic neobladders. 150
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 150
Bradeion (SEPT4) as a Urinary Marker of Transitional Cell Bladder Cancer: A Real-Time Polymerase Chain Reaction Study of Gene Expression 150
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 149
[Innovative treatments of non muscle invasive bladder cancer] 148
Advanced bladder cancer: New agents and new approaches. A review 147
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 147
Imaging in prostate cancer staging: present role and future perspectives 145
Circumcision: history, religion and law 142
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 142
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 140
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 140
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 140
Is extracorporeal shock wave lithotripsy in pediatrics a safe procedure? 137
Postoperative nomogram for invasive bladder cancer: Does it really work? A multicenter cohort study 137
Improved non-invasive diagnosis of bladder cancer with an electronic nose: A large pilot study 135
Imaging of renal cell carcinoma: state of the art and recent advances 133
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 132
Mitomycin C: new strategies to improve efficacy of a well-known therapy 132
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 131
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 131
The occult urothelial cancer 131
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 130
Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit 130
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 130
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. 128
Second-line intravesical therapy. What is the present role of device-assisted therapy? 127
Therapy for non-muscle invasive bladder cancer: HP-NAP 125
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 124
Vitamin B12 and folic acid plasma levels after ileocecal and ileal neobladder reconstruction 124
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study 124
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 124
Simultaneous surgical management of renal cancer with atrial thrombotic extension and severe chronic coronary artery disease: a case report 123
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study 122
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 122
Imaging in prostate cancer diagnosis: present role and future perspectives 121
Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approach. 119
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 117
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients 114
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer? 113
Quality of life following urinary diversion: Orthotopic ileal neobladder versus ileal conduit. A multicentre study among long-term, female bladder cancer survivors 112
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process 111
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 110
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 110
Predictive Factors for Major Complications and Urological Cancer Diagnosis in Older Adults (≥80 Years) Admitted to the Emergency Department for Hematuria 109
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 107
Imaging of renal cell carcinoma: state of the art and recent advances. 105
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 104
Sports and Genitourinary Traumas 104
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy 103
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation 103
Classification and management of sexual dysfunctions in multiple sclerosis patients: A review of current literature 102
Totale 30.148
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.058
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 0 0 65
2021/20221.385 136 86 45 104 110 77 56 174 94 81 189 233
2022/20234.082 416 397 268 493 215 396 196 338 441 213 400 309
2023/20245.933 330 583 373 514 407 456 453 575 426 565 559 692
2024/20258.328 580 690 746 629 798 608 619 647 946 653 797 615
2025/20268.330 1.204 375 513 801 1.286 511 1.446 482 559 557 369 227
Totale 33.401